+91-8668442535

Listeria Monocytogenes Infections Treatment Market By Type Of Infection (Bacteremia, Meningitis, Brain Abscess, Gastroenteritis, Endocarditis, Pipeline Analysis) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

This report on the global Listeria monocytogenes infections treatment market studies various drugs used for the treatment of Listeria monocytogenes infections along with pipeline analysis of upcoming potential drugs. According to the Centers for Disease Control and Prevention (CDC), Listeriosis, a serious infection usually caused by eating food contaminated with the bacterium Listeria monocytogenes, is an important public health problem in the United States. In addition, CDC estimates that approximately 1600 illnesses and 260 deaths due to Listeriosis occur annually in the United States. Thus, the drug pipeline of the Listeria monocytogenes infections treatment market comprises potential drugs which are more target-specific and possess innovative properties.

For the purpose of this study, the various infection types studied include bacteremia, meningitis, brain abscess, gastroenteritis, endocarditis, and others. Market size estimates and forecasts for these segments for 2013 to 2022 are provided in terms of USD Mn and the respective CAGRs for 2016 to 2022, considering 2015 as the base year.

The pipeline analysis for the Listeria monocytogenes infections treatment market comprises projected market sales of Phase III drugs estimated till 2022. The phase III drugs included in the pipeline analysis are Carbavance (The Medicines Company), Telavancin (Theravance Biopharma Antibiotics, Inc.), Daptomycin (Merck & Co.), Prulifloxacin (Merck & Co.), and DTaP-IPV/Hib combined vaccine (Sanofi S.A.). In addition, the report also covers qualitative information associated with the drugs under phases II and I of the clinical trials.

The geographic segmentation of the global Listeria monocytogenes infections treatment market is performed for North America, Europe, Asia Pacific, and the Rest of the world. The regions are also further sub-segmented on the basis of major countries. Market size estimates and forecasts for these segments for 2013 to 2022 are provided in terms of USD Mn, along with the respective CAGRs for the period 2016 to 2022, considering 2015 as the base year.

Frequently asked questions :

The market for Listeria Monocytogenes Infections Treatment Market is expected to reach US$ 5,056.3 Mn By 2022.

The Listeria Monocytogenes Infections Treatment Market is expected to see significant CAGR growth over the coming years, at 4.74%.

The report is forecasted from 2016-2022.

The base year of this report is 2021.

Pfizer Inc., Novartis AG, Merck & Co., Astra Zeneca plc, Johnson & Johnson Limited are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  May 2016
Category:  Pharmaceuticals
Report ID:   57831
Report Format:   PDF
Pages:   120
Rating:    4.1 (40)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support